デフォルト表紙
市場調査レポート
商品コード
1392514

バイオマーカーの世界市場レポート 2024年

Biomarkers Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
バイオマーカーの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

バイオマーカーの市場規模は近年急速に拡大しています。2023年の613億1,000万米ドルから2024年には695億4,000万米ドルへと、CAGR13.4%で拡大します。過去の期間の成長は、ゲノミクスとプロテオミクス技術の進歩、慢性疾患の有病率の増加、個別化医療の重視の高まり、コンパニオン診断の需要の高まり、医薬品開発における用途の拡大に起因しています。

心臓疾患の増加は、予測期間におけるバイオマーカー市場の成長を促進すると予想されます。心臓病患者に対するバイオマーカーの使用は、ここ数年で飛躍的に増加しています。現在、ナトリウム利尿ペプチドは最も使用されているバイオマーカーであり、心不全患者の診断に役立っています。心不全の診断には、高感度C反応性蛋白を用いた循環バイオマーカーなどが用いられます。心臓病は、米国のほとんどの人種・民族の主要な死因の一つです。心臓病の増加は、バイオマーカーの需要を促進します。例えば2022年8月、米国の非営利医療団体である米国心臓病学会(American College of Cardiology)が発表したレポートによると、米国では2025年から2060年の間に4つの心血管危険因子すべてが増加すると予測されています。最も増加率が高いのは糖尿病で39.3%・5,500万人、次いで脂質異常症(27.6%・1億2,600万人)、高血圧(25.1%・1億6,200万人)、肥満(18.3%・1億2,600万人)が続く。また、調査結果によると、心血管疾患罹患率が最も大幅に増加すると予測されたのは、脳卒中(33.8%・1,500万人)と心不全(33.4%・1,300万人)で、虚血性心疾患(30.7%・2,900万人)と心臓発作(16.9%・1,600万人)がこれに続いた。心臓病と心臓死が増加しているため、バイオマーカーの伸びも増加します。

高齢者人口の増加は、今後のバイオマーカー市場の成長を押し上げると予想されます。高齢者人口とは、18~64歳の就業者に占める65歳以上の人口の割合を指します。慢性疾患やがんなど、さまざまな疾患に対する高齢者の脆弱性が高まっていることから、しばしばバイオマーカーに依存した早期発見やモニタリングの必要性が強調されています。例えば、2022年10月、スイスに本部を置く国際的な公衆衛生を担当する機関である世界保健機関(WHO)が発表した報告書によると、2030年までに全世界で6人に1人が60歳以上になると予想されています。2050年には、60歳以上の高齢者は世界で21億人になるといわれています。したがって、高齢者人口の増加がバイオマーカー市場の成長を牽引しています。

2023年のバイオマーカー市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。バイオマーカー市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 バイオマーカー市場の特徴

第3章 バイオマーカー市場の動向と戦略

第4章 バイオマーカー市場-マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のバイオマーカー市場規模と成長

  • 世界のバイオマーカー市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のバイオマーカーの市場規模実績と成長、2018~2023年
  • 世界のバイオマーカー市場規模と成長予測、2023~2028年、2033年

第6章 バイオマーカー市場セグメンテーション

  • 世界のバイオマーカー市場、タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 暴露のバイオマーカー
  • 病気のバイオマーカー
  • 世界のバイオマーカー市場、技術別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 安全性バイオマーカー
  • 有効性バイオマーカー
  • 検証バイオマーカー
  • 世界のバイオマーカー市場、疾患別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 神経疾患
  • がん
  • 免疫疾患
  • 心血管疾患
  • その他の病気
  • 世界のバイオマーカー市場、視聴者別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 製薬会社
  • 政府と民間の研究機関
  • 学術機関
  • 医療機器製造会社
  • 世界のバイオマーカー市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • リスクアセスメント
  • 分子診断法の開発
  • 病気の診断
  • 創薬と開発
  • 医薬品の製剤化
  • フォレンジック用途
  • その他の用途(DNAフィンガープリンティングとその他)

第7章 バイオマーカー市場の地域と国分析

  • 世界のバイオマーカー市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界のバイオマーカー市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋のバイオマーカー市場

第9章 中国のバイオマーカー市場

第10章 インドのバイオマーカー市場

第11章 日本のバイオマーカー市場

第12章 オーストラリアのバイオマーカー市場

第13章 インドネシアのバイオマーカー市場

第14章 韓国のバイオマーカー市場

第15章 西欧のバイオマーカー市場

第16章 英国のバイオマーカー市場

第17章 ドイツのバイオマーカー市場

第18章 フランスのバイオマーカー市場

第19章 イタリアのバイオマーカー市場

第20章 スペインのバイオマーカー市場

第21章 東欧のバイオマーカー市場

第22章 ロシアのバイオマーカー市場

第23章 北米のバイオマーカー市場

第24章 米国のバイオマーカー市場

第25章 カナダのバイオマーカー市場

第26章 南米のバイオマーカー市場

第27章 ブラジルのバイオマーカー市場

第28章 中東のバイオマーカー市場

第29章 アフリカのバイオマーカー市場

第30章 バイオマーカー市場の競合情勢と企業プロファイル

  • バイオマーカー市場の競合情勢
  • バイオマーカー市場の企業プロファイル
    • Enzo Biochem Inc
    • Bio-Rad Laboratories Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN N. V.

第31章 世界のバイオマーカー市場の競合ベンチマーキング

第32章 世界のバイオマーカー市場の競合ダッシュボード

第33章 バイオマーカー市場における主要な合併と買収

第34章 バイオマーカー市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10202

“Biomarkers Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomarkers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The biomarkers market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Safety Biomarkers; Efficacy Biomarkers; Validation Biomarkers
  • 2) By Disease: Neurological Diseases; Cancer; Immunological Diseases; Cardiovascular Diseases; Other Diseases
  • 3) By Type: Biomarker Of Exposure; Biomarker Of Diseases
  • 4) By Audiences: Pharmaceutical Companies; Government And Private Research Institutes; Academic Institutes; Medical Device Manufacturing Companies
  • 5) By Application: Risk Assessment; Development of Molecular Diagnostic; Disease Diagnosis; Drug Discovery And Development; Drug Formulation; Forensic Application; Other Applications (DNA Fingerprinting And Others )
  • Companies Mentioned: Enzo Biochem Inc; Bio-Rad Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; QIAGEN N. V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. It is used to determine how well the body responds to a disease or condition's treatment. These biomarkers have a clinical role in narrowing or guiding treatment decisions.

The main types of biomarkers are biomarker of exposure and biomarker of diseases. The biomarker of exposure is a substance corresponding to the chemical that may be found in the body. When a person is exposed to chemicals by direct contact, inhaling or ingesting helps to identify them. Various technologies used for biomarker are safety biomarkers, efficacy biomarkers, and validation biomarkers used to treat diseases such as neurological diseases, cancer, immunological diseases, cardiovascular diseases, and other. These biomarker are used by pharmaceutical companies, government and private research institutes, academic institutes, and medical device manufacturing companies for risk assessment, the development of molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic application and others (DNA fingerprinting, and others).

The biomarkers market research report is one of a series of new reports from The Business Research Company that provides biomarkers market statistics, including biomarkers industry global market size, regional shares, competitors with a biomarkers market share, detailed biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the biomarkers industry. This biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomarkers market size has grown rapidly in recent years. It will grow from $61. 31 billion in 2023 to $69. 54 billion in 2024 at a compound annual growth rate (CAGR) of 13. 4%. The growth in the historic period can be attributed to advancements in genomics and proteomics technologies, increasing prevalence of chronic diseases, growing emphasis on personalized medicine, rising demand for companion diagnostics, expansion of applications in drug development.

The biomarkers market size is expected to see rapid growth in the next few years. It will grow to $117. 82 billion in 2028 at a compound annual growth rate (CAGR) of 14. 1%. The growth in the forecast period can be attributed to growing focus on early disease detection and prevention, expansion of biomarkers in oncology and immunotherapy, increasing investment in precision medicine initiatives, rise of liquid biopsy as a non-invasive biomarker detection method,rising preference of biomarkers in drug discovery and development. Major trends in the forecast period include development of multi-biomarker panels, emergence of exosome-based biomarkers, adoption of point-of-care biomarker testing, integration of real-world data in biomarker research, exploration of microbiome-based biomarkers .

The increase in heart diseases is expected to propel the growth of the biomarkers market in the forecasted period. The use of biomarkers for heart disease patients has increased tremendously over the last few years. Currently, the natriuretic peptides are the most used biomarker and help in the diagnosis of patients with heart failure. Biomarkers such as circulating biomarkers with high sensitivity C-reactive protein are used for the diagnosis of heart failure. Heart disease is among leading cause of death for people of most racial and ethnic groups in the United States. The increase in heart diseases will drive the demand for biomarkers. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, In the United States, it is anticipated that all four cardiovascular risk factors will increase between 2025 and 2060. The largest percentage rise is expected in diabetes, with a 39. 3% increase to 55 million individuals, followed by dyslipidemia (27. 6% to 126 million), hypertension (25. 1% to 162 million), and obesity (18. 3% to 126 million). The researchers also observed that the most substantial projected increases in cardiovascular disease rates were for stroke (33. 8% to 15 million) and heart failure (33. 4% to 13 million), followed by ischemic heart disease (30. 7% to 29 million) and heart attack (16. 9% to 16 million). Because of the increase in heart diseases and heart deaths, there will be an increase in growth for the biomarkers.

The increase in the geriatric population is expected to boost the growth of the biomarker market going forward. The geriatric population refers to the percentage of people 65 and older to those between the ages of 18 and 64 who are employed. The elevated vulnerability of elderly individuals to various diseases, including chronic conditions and cancer, underscores the need for early detection and monitoring, often reliant on biomarkers. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2. 1 billion people worldwide who are 60 years old or older. Therefore, the increase in the geriatric population is driving the growth of the biomarker market.

Major companies operating in the biomarker market are adopting strategic partnerships approach to provide expanded decentralized clinical trials to individuals, businesses, and governments. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2021, Medidata, a US-based technology company, partnered with Labcorp, a US-based healthcare company. Under this partnership, Medidata receives and processes medical-grade sensor data in drug, vaccine, and device trials within Labcorp Drug Development's clinical trial portfolio, bolstering its decentralized clinical trial (DCT) offerings. Leveraging Medidata Sensor Cloud, LabCorp enhances its decentralized clinical trial offerings by collecting and processing medical-grade sensor data in drug, vaccine, and device trials, with the aim of expediting and enhancing patient outcomes. Additionally, Labcorp and Medidata collaborate on co-developing digital biomarkers spanning a wide range of medical devices and therapeutic areas, with the objective of establishing a library of digital biomarkers for advancing therapeutic research and developing new digital diagnostics.

Major companies operating in the biomarker market are developing innovative products such as biomarker tests to meet larger customer bases, more sales, and increase revenue. Biomarker tests, also known as biomarker assays, are laboratory techniques or diagnostic tests that measure specific biological markers, which can include molecules, genes, proteins, or other substances, to provide information about various physiological or pathological processes in the body. For instance, in July 2023, Quest Diagnostics, a US-based medical laboratories company, launched a novel prostate cancer biomarker test. The newly introduced tissue-based test service aims to meet the urgent clinical demand for tests that can assist in distinguishing potentially aggressive cases of prostate cancer in males. Quest has created and validated this laboratory test through an intellectual property license agreement with Envision, allowing the utilization of Envision's exclusive biomarker and immunohistochemistry technology, incorporating Envision's distinct staining methods and innovative biomarkers referred to as EV1, EV2, and EV3.

In July 2023, Biocare Medical, a US-based biotechnology company, acquired Empire Genomics for an undisclosed amount. Through this acquisition, Biocare is broadening its molecular portfolio, encompassing more than 1 million biomarkers, and introducing swift biomarker development to advance cancer research leadership. Biocare Medical's expanded molecular menu, coupled with its state-of-the-art automation platforms such as the ONCORE Pro X, will empower researchers to accelerate their work, expediting cancer diagnostics for improved patient outcomes at an unprecedented pace. Empire Genomics is a US-based biotechnology company.

Major companies operating in the in the biomarkers market report are Enzo Biochem Inc, Bio-Rad Laboratories Inc. , Merck KGaA, PerkinElmer Inc. , QIAGEN N. V. , Adaptive Biotechnologies Corp. , Agilent Technologies Inc. , Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc. , Bio-Techne Corporation, Cepheid Inc. , Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc. , Genomic Health Inc. , GenScript Biotech Corporation, Guardant Health Inc. , Illumina Inc. , Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc. , Myriad Genetics Inc. , Natera Inc. , Pacific Biosciences of California Inc. , Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc. , Veracyte Inc.

North America was the largest region in the biomarkers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biomarkers market consists of sales of molecular biomarkers, cellular biomarkers or imaging biomarkers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Biomarkers Market Characteristics

3. Biomarkers Market Trends And Strategies

4. Biomarkers Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biomarkers Market Size and Growth

  • 5.1. Global Biomarkers Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biomarkers Market Segmentation

  • 6.1. Global Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biomarker Of Exposure
  • Biomarker Of Diseases
  • 6.2. Global Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers
  • 6.3. Global Biomarkers Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Neurological Diseases
  • Cancer
  • Immunological Diseases
  • Cardiovascular Diseases
  • Other Diseases
  • 6. 4. Global Biomarkers Market, Segmentation By Audiences, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Government And Private Research Institutes
  • Academic Institutes
  • Medical Device Manufacturing Companies
  • 6. 5. Global Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Risk Assessment
  • Development of Molecular Diagnostic
  • Disease Diagnosis
  • Drug Discovery And Development
  • Drug Formulation
  • Forensic Application
  • Other Applications (DNA Fingerprinting And Others )

7. Biomarkers Market Regional And Country Analysis

  • 7.1. Global Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biomarkers Market

  • 8.1. Asia-Pacific Biomarkers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8. 4. Asia-Pacific Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biomarkers Market

  • 9.1. China Biomarkers Market Overview
  • 9.2. China Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9. 4. China Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biomarkers Market

  • 10.1. India Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biomarkers Market

  • 11.1. Japan Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biomarkers Market

  • 12.1. Australia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biomarkers Market

  • 13.1. Indonesia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biomarkers Market

  • 14.1. South Korea Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biomarkers Market

  • 15.1. Western Europe Biomarkers Market Overview
  • 15.2. Western Europe Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15. 4. Western Europe Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biomarkers Market

  • 16.1. UK Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biomarkers Market

  • 17.1. Germany Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biomarkers Market

  • 18. 5. France Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 6. France Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18. 7. France Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biomarkers Market

  • 19. 9. Italy Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biomarkers Market

  • 20.13. Spain Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biomarkers Market

  • 21.1. Eastern Europe Biomarkers Market Overview
  • 21.2. Eastern Europe Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21. 4. Eastern Europe Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biomarkers Market

  • 22.1. Russia Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biomarkers Market

  • 23.1. North America Biomarkers Market Overview
  • 23.2. North America Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23. 4. North America Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biomarkers Market

  • 24.1. USA Biomarkers Market Overview
  • 24.2. USA Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24. 4. USA Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biomarkers Market

  • 25.1. Canada Biomarkers Market Overview
  • 25.2. Canada Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25. 4. Canada Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biomarkers Market

  • 26.1. South America Biomarkers Market Overview
  • 26.2. South America Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26. 4. South America Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biomarkers Market

  • 27.1. Brazil Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biomarkers Market

  • 28.1. Middle East Biomarkers Market Overview
  • 28.2. Middle East Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28. 4. Middle East Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biomarkers Market

  • 29.1. Africa Biomarkers Market Overview
  • 29.2. Africa Biomarkers Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29. 4. Africa Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biomarkers Market Competitive Landscape And Company Profiles

  • 30.1. Biomarkers Market Competitive Landscape
  • 30.2. Biomarkers Market Company Profiles
    • 30.2.1. Enzo Biochem Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1. 4. Financial Performance
    • 30.2.2. Bio-Rad Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2. 4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3. 4. Financial Performance
    • 30.2. 4. PerkinElmer Inc.
      • 30.2. 4.1. Overview
      • 30.2. 4.2. Products and Services
      • 30.2. 4.3. Strategy
      • 30.2. 4. 4. Financial Performance
    • 30.2. 5. QIAGEN N. V.
      • 30.2. 5.1. Overview
      • 30.2. 5.2. Products and Services
      • 30.2. 5.3. Strategy
      • 30.2. 5. 4. Financial Performance

31. Global Biomarkers Market Competitive Benchmarking

32. Global Biomarkers Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biomarkers Market

34. Biomarkers Market Future Outlook and Potential Analysis

  • 34.1 Biomarkers Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Biomarkers Market In 2028 - Segments Offering Most New Opportunities
  • 34. 3 Biomarkers Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35. 4. Research Inquiries
  • 35. 5. The Business Research Company
  • 35. 6. Copyright And Disclaimer